Access Will Become Commoditized
Providers’ strategic control and differentiation will shift to be based on experience, ease of use, and price.
_145x171.jpg)
Plus, Why We Should Still Be Thinking About Cumulative Population Immunity
Three takeaways from our analysis on possible Herd Immunity Threshold and how to reach it together.
An Analysis of Infection Odds Based on US County
Our new model projects the chance that within a gathering of random people, there's an active COVID-19 infection.
Drive Innovation
March 16, 2021
The COVID-19 Long Haul, One Year Later
Timeline to Normalcy - Updated March 15, 2021
Our revised analysis and state-by-state outlook suggest the US may achieve pHIT in early summer if vaccinations align with a more optimistic scenario.
Timeline to Normalcy - Updated January 25, 2021
The journey to normalcy involves understanding and addressing many different factors. Our latest analysis suggests we are likely to achieve pHIT in the US on average in late summer.
Hospitals nationwide could near collapse as the pandemic straps them of necessary resources.
New Predictions on COVID-19 Vaccines and Herd Immunity
How COVID-19 case counts and vaccines may get us back to normalcy by June.
Transform Care
November 16, 2020
Pandemic Forecast: Herd Immunity and Vaccine Distribution
New Oliver Wyman analysis on when and how a vaccine may be available and key considerations for how to reach herd immunity.
The nation's new "normal" may not come until Q4 of 2021. Companies must consider what is sustainable and where to adjust for the long haul.
Returning to work, school, and daily life in a recovering economy means co-existing with COVID-19.
